Literature DB >> 30405905

Effects of D-Lysine Substitutions on the Activity and Selectivity of Antimicrobial Peptide CM15.

Heather M Kaminski1, Jimmy B Feix1.   

Abstract

Despite their potent antimicrobial activity, the usefulness of antimicrobial peptides (AMPs) as antibiotics has been limited by their toxicity to eukaryotic cells and a lack of stability in vivo. In the present study we examined the effects of introducing D-lysine residues into a 15-residue hybrid AMP containing residues 1-7 of cecropin A and residues 2-9 of melittin (designated CM15). Diastereomeric analogs of CM15 containing between two and five D-lysine substitutions were evaluated for their antimicrobial activity, lysis of human erythrocytes, toxicity to murine macrophages, ability to disrupt cell membranes, and protease stability. All of the analogs caused rapid permeabilization of the Staphylococcus aureus cell envelope, as indicated by uptake of SYTOX green. CM15 also permeabilized the plasma membrane of RAW264.7 macrophages, but this was substantially diminished for the D-lysine containing analogs. The introduction of D-lysine caused moderate decreases in antimicrobial activity for all analogs studied. However, D-Lys substitution produced a much more pronounced reduction in toxicity to eukaryotic cells, leading to marked improvements in antimicrobial efficacy for some analogs. Circular dichroism studies indicated a progressive loss of helical secondary structure upon introduction of D-lysine residues, and there was a good correspondence between helical content and eukaryotic cell cytotoxicity. Overall, these studies show that the biological activity of CM15 analogs containing D-lysine depends on both the number and position of D-Lys substitutions, and that such substitutions can dramatically lower toxicity to eukaryotic cells with only minimal decreases in antimicrobial activity.

Entities:  

Year:  2011        PMID: 30405905      PMCID: PMC6217857          DOI: 10.3390/polym3042088

Source DB:  PubMed          Journal:  Polymers (Basel)        ISSN: 2073-4360            Impact factor:   4.329


  51 in total

1.  Action of antimicrobial peptides: two-state model.

Authors:  H W Huang
Journal:  Biochemistry       Date:  2000-07-25       Impact factor: 3.162

2.  In vitro activity and mode of action of diastereomeric antimicrobial peptides against bacterial clinical isolates.

Authors:  U Pag; M Oedenkoven; N Papo; Z Oren; Y Shai; H-G Sahl
Journal:  J Antimicrob Chemother       Date:  2004-01-16       Impact factor: 5.790

3.  Antibacterial peptides designed as analogs or hybrids of cecropins and melittin.

Authors:  D Wade; D Andreu; S A Mitchell; A M Silveira; A Boman; H G Boman; R B Merrifield
Journal:  Int J Pept Protein Res       Date:  1992-11

4.  Amphipathic antimicrobial peptides--from biophysics to therapeutics?

Authors:  Christopher E Dempsey; Ayman Hawrani; Robin A Howe; Timothy R Walsh
Journal:  Protein Pept Lett       Date:  2010-11       Impact factor: 1.890

5.  Interplay among folding, sequence, and lipophilicity in the antibacterial and hemolytic activities of alpha/beta-peptides.

Authors:  Margaret A Schmitt; Bernard Weisblum; Samuel H Gellman
Journal:  J Am Chem Soc       Date:  2007-01-17       Impact factor: 15.419

Review 6.  Molecular mechanisms of antibacterial multidrug resistance.

Authors:  Michael N Alekshun; Stuart B Levy
Journal:  Cell       Date:  2007-03-23       Impact factor: 41.582

7.  Origin of low mammalian cell toxicity in a class of highly active antimicrobial amphipathic helical peptides.

Authors:  Ayman Hawrani; Robin A Howe; Timothy R Walsh; Christopher E Dempsey
Journal:  J Biol Chem       Date:  2008-04-23       Impact factor: 5.157

8.  Basis for selectivity of cationic antimicrobial peptides for bacterial versus mammalian membranes.

Authors:  Evgenia Glukhov; Margareta Stark; Lori L Burrows; Charles M Deber
Journal:  J Biol Chem       Date:  2005-07-25       Impact factor: 5.157

Review 9.  Pseudomonas aeruginosa virulence and therapy: evolving translational strategies.

Authors:  Jeffrey L Veesenmeyer; Alan R Hauser; Thiago Lisboa; Jordi Rello
Journal:  Crit Care Med       Date:  2009-05       Impact factor: 7.598

10.  Retro and retroenantio analogs of cecropin-melittin hybrids.

Authors:  R B Merrifield; P Juvvadi; D Andreu; J Ubach; A Boman; H G Boman
Journal:  Proc Natl Acad Sci U S A       Date:  1995-04-11       Impact factor: 11.205

View more
  4 in total

1.  Gentamicin-Loaded Chitosan Nanoparticles Improve Its Therapeutic Effects on Brucella-Infected J774A.1 Murine Cells.

Authors:  Ali Razei; Abdol Majid Cheraghali; Mojtaba Saadati; Mahdi Fasihi Ramandi; Yunes Panahi; Abbas Hajizade; Seyed Davar Siadat; Ava Behrouzi
Journal:  Galen Med J       Date:  2019-10-29

2.  D- and Unnatural Amino Acid Substituted Antimicrobial Peptides With Improved Proteolytic Resistance and Their Proteolytic Degradation Characteristics.

Authors:  Jianguang Lu; Hongjiang Xu; Jianghua Xia; Jie Ma; Jun Xu; Yanan Li; Jun Feng
Journal:  Front Microbiol       Date:  2020-11-12       Impact factor: 5.640

3.  Helical structure motifs made searchable for functional peptide design.

Authors:  Cheng-Yu Tsai; Emmanuel Oluwatobi Salawu; Hongchun Li; Guan-Yu Lin; Ting-Yu Kuo; Liyin Voon; Adarsh Sharma; Kai-Di Hu; Yi-Yun Cheng; Sobha Sahoo; Lutimba Stuart; Chih-Wei Chen; Yuan-Yu Chang; Yu-Lin Lu; Simai Ke; Christopher Llynard D Ortiz; Bai-Shan Fang; Chen-Chi Wu; Chung-Yu Lan; Hua-Wen Fu; Lee-Wei Yang
Journal:  Nat Commun       Date:  2022-01-10       Impact factor: 17.694

4.  Modification Strategy of D-leucine Residue Addition on a Novel Peptide from Odorrana schmackeri, with Enhanced Bioactivity and In Vivo Efficacy.

Authors:  Aifang Yao; Yingxue Ma; Xiaoling Chen; Mei Zhou; Xinping Xi; Chengbang Ma; Shen Ren; Tianbao Chen; Chris Shaw; Lei Wang
Journal:  Toxins (Basel)       Date:  2021-08-31       Impact factor: 4.546

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.